Treatment of melasma on darker skin types : a scoping review

dc.contributor.authorMpofana, Nomakhosi
dc.contributor.authorChibi, Buyisile
dc.contributor.authorVisser, Tronel
dc.contributor.authorPaulse, Michael
dc.contributor.authorFinlayson, Avenal Jane
dc.contributor.authorGhuman, Shanaz
dc.contributor.authorHussein, Ahmed A.
dc.contributor.authorDlova, Ncoza Cordelia
dc.date.accessioned2024-05-14T05:07:02Z
dc.date.available2024-05-14T05:07:02Z
dc.date.issued2023-01-27
dc.descriptionSUPPLEMENTARY MATERIALS : The following supporting information can be downloaded at: 10.6084/m9.figshare.21730970 (accessed on 27 January 2022): FILE S1: Table 3: Results from searched databases; FILE S2: MMAT quality appraisal reviewer 1; FILE S3: MMAT quality appraisal reviewer 2; and FILE S4: Preferred reporting items for systematic reviews and meta-analyses extensions for scoping reviews (PRISMA-ScR) checklist.en_US
dc.description.abstractMelasma is a challenging chronic skin condition associated with hyperpigmentation and unknown aetiology. This scoping review maps evidence of available treatments and their effectiveness in darker skin types. A comprehensive, systematic online search was conducted in Scopus, PubMed, CINAHL Complete, Cochrane, ScienceDirect, andWeb of Science Core Collection. All eligible titles were exported to an EndNote20 library (Clarivate analytics, US). Thematic content analysis was performed to summarise data on current melasma treatments for darker skin types. The quality of included articles was appraised using the Mixed Methods Appraisal Tool (MMAT) 2018 version. A total of 2863 articles were retrieved from the databases, and 10 met the eligibility criteria following abstract and full-text screening. Our findings demonstrate that topical treatments, chemical peels, lasers, and tranexamic acid are common treatment modalities used in darker skin types. Although these treatments may be effective in the short term, they bring about undesirable side effects and sometimes worsen or result in reoccurrences of melasma. Based on the evidence mapped, current treatment modalities are not suitable for darker skin types. There are very few studies conducted on individuals of African descent. Further research is necessary to investigate treatment interventions that may be user-friendly when dealing with darker skin types.en_US
dc.description.departmentSchool of Health Systems and Public Health (SHSPH)en_US
dc.description.librarianam2024en_US
dc.description.sdgSDG-03:Good heatlh and well-beingen_US
dc.description.sponsorshipIn part by the National Research Foundation of South Africa, the HWSETA bursary, Durban University of Technology Seed Funding grant, and funding from UNICEF and with support from Future Africa, the University of Pretoria.en_US
dc.description.urihttps://www.mdpi.com/journal/cosmeticsen_US
dc.identifier.citationMpofana, N.; Chibi, B.; Visser, T.; Paulse, M.; Finlayson, A.J.; Ghuman, S.; Gqaleni, N.; Hussein, A.A.; Dlova, N.C. Treatment of Melasma on Darker Skin Types: A Scoping Review. Cosmetics 2023, 10, 25. https://DOI.org/10.3390/cosmetics10010025.en_US
dc.identifier.issn2079-9284 (online)
dc.identifier.other10.3390/cosmetics10010025
dc.identifier.urihttp://hdl.handle.net/2263/95933
dc.language.isoenen_US
dc.publisherMDPIen_US
dc.rights© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.en_US
dc.subjectMelasmaen_US
dc.subjectTreatmenten_US
dc.subjectDarker skin typesen_US
dc.subjectFitzpatrick skin types IV–VIen_US
dc.subjectMapping reviewen_US
dc.subjectSDG-03: Good health and well-beingen_US
dc.subjectMixed methods appraisal tool (MMAT)en_US
dc.titleTreatment of melasma on darker skin types : a scoping reviewen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 5 of 5
Loading...
Thumbnail Image
Name:
Mpofana_Treatment_2023.pdf
Size:
473.38 KB
Format:
Adobe Portable Document Format
Description:
Article
Loading...
Thumbnail Image
Name:
Mpofana_TreatmentFileS1_2023.docx
Size:
13.78 KB
Format:
Microsoft Word XML
Description:
File S1
Loading...
Thumbnail Image
Name:
Mpofana_TreatmentFileS2_2023.xlsx
Size:
65.65 KB
Format:
Microsoft Excel XML
Description:
File S2
Loading...
Thumbnail Image
Name:
Mpofana_TreatmentFileS3_2023.xlsx
Size:
65.5 KB
Format:
Microsoft Excel XML
Description:
File S3
Loading...
Thumbnail Image
Name:
Mpofana_TreatmentFileS4_2023.pdf
Size:
497.39 KB
Format:
Adobe Portable Document Format
Description:
File S4

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: